Schonfeld Strategic Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,644
| Closed | -$501K | – | 2066 |
|
|
2024
Q4 | $501K | Sell |
47,644
-22,256
| -32% | -$234K | ﹤0.01% | 1334 |
|
|
2024
Q3 | $917K | Buy |
69,900
+158
| +0.2% | +$2.07K | 0.01% | 1061 |
|
|
2024
Q2 | $981K | Sell |
69,742
-252,258
| -78% | -$3.55M | 0.01% | 1097 |
|
|
2024
Q1 | $5.44M | Buy |
+322,000
| New | +$5.44M | 0.04% | 516 |
|
|
2020
Q3 | – | Sell |
-57,300
| Closed | -$463K | – | 1315 |
|
|
2020
Q2 | $463K | Buy |
+57,300
| New | +$463K | 0.01% | 788 |
|